-
US talking deal with 'highest people' in Cuba: Trump
-
UK ex-ambassador quits Labour over new reports of Epstein links
-
Trump says closing Kennedy Center arts complex for two years
-
Reigning world champs Tinch, Hocker among Millrose winners
-
Venezuelan activist ends '1,675 days' of suffering in prison
-
Real Madrid scrape win over Rayo, Athletic claim derby draw
-
PSG beat Strasbourg after Hakimi red to retake top spot in Ligue 1
-
NFL Cardinals hire Rams' assistant LaFleur as head coach
-
Arsenal scoop $2m prize for winning FIFA Women's Champions Cup
-
Atletico agree deal to sign Lookman from Atalanta
-
Real Madrid's Bellingham set for month out with hamstring injury
-
Man City won't surrender in title race: Guardiola
-
Korda captures weather-shortened LPGA season opener
-
Czechs rally to back president locking horns with government
-
Prominent Venezuelan activist released after over four years in jail
-
Emery riled by 'unfair' VAR call as Villa's title hopes fade
-
Guirassy double helps Dortmund move six points behind Bayern
-
Nigeria's president pays tribute to Fela Kuti after Grammys Award
-
Inter eight clear after win at Cremonese marred by fans' flare flinging
-
England underline World Cup
credentials with series win over Sri Lanka
-
Guirassy brace helps Dortmund move six behind Bayern
-
Man City held by Solanke stunner, Sesko delivers 'best feeling' for Man Utd
-
'Send Help' debuts atop N.America box office
-
Ukraine war talks delayed to Wednesday, says Zelensky
-
Iguanas fall from trees in Florida as icy weather bites southern US
-
Carrick revels in 'best feeling' after Man Utd leave it late
-
Olympic chiefs admit 'still work to do' on main ice hockey venue
-
Pope says Winter Olympics 'rekindle hope' for world peace
-
Last-gasp Demirovic strike sends Stuttgart fourth
-
Sesko strikes to rescue Man Utd, Villa beaten by Brentford
-
'At least 200' feared dead in DR Congo landslide: government
-
Coventry says 'sad' about ICE, Wasserman 'distractions' before Olympics
-
In-form Lyon make it 10 wins in a row
-
Man Utd strike late as Carrick extends perfect start in Fulham thriller
-
Van der Poel romps to record eighth cyclo-cross world title
-
Mbappe penalty earns Real Madrid late win over nine-man Rayo
-
Resurgent Pakistan seal T20 sweep of Australia
-
Fiji top sevens standings after comeback win in Singapore
-
Alcaraz sweeps past Djokovic to win 'dream' Australian Open
-
Death toll from Swiss New Year bar fire rises to 41
-
Alcaraz says Nadal inspired him to 'special' Australian Open title
-
Pakistan seeks out perpetrators after deadly separatist attacks
-
Ukraine war talks delayed to Wednesday, Zelensky says
-
Djokovic says 'been a great ride' after Melbourne final loss
-
Von Allmen storms to downhill win in final Olympic tune-up
-
Carlos Alcaraz: tennis history-maker with shades of Federer
-
Alcaraz sweeps past Djokovic to win maiden Australian Open title
-
Israel says partially reopening Gaza's Rafah crossing
-
French IT giant Capgemini to sell US subsidiary after row over ICE links
-
Iran's Khamenei likens protests to 'coup', warns of regional war
Brazil's banana spider aids erectile dysfunction treatment
Three decades ago, Brazilian researchers began studying a curious side effect from banana spider bites: the toxin left victims with priapism, a painful and persistent erection.
The scientists were inspired to develop a synthetic molecule using some properties of the spider's poison to create a gel to treat erectile dysfunction, which is now undergoing promising clinical trials.
Covered in thick brown hair, and with a maximum size of up to 15 centimeters (six inches), the arachnid is one of the most poisonous in the world.
It is found in several South American countries, and was nicknamed for its common presence in banana plantations, but it is also called the "wandering spider" or "armed spider."
In the southeastern Brazilian state of Minas Gerais, it is found in rural areas as well as urban centers.
At the Ezequiel Dias Foundation (FUNED), a medical research center in the state's capital Belo Horizonte, a biologist delicately grabs one of the spiders with a pair of tweezers and stimulates its fangs to get a few drops of venom.
FUNED then sends the venom to the Federal University of Minas Gerais (UFMG) which has been researching which component could be replicated to treat erectile dysfunction, which affects tens of millions of men around the world.
"The venom is only used to learn the properties of the molecule" which causes the priapism in bite victims, said Maria Elena de Lima, a UFMG researcher.
Brazilian biotech company Biozeus has bought the patent for the molecule.
The company wants to sell it in an ointment, which would be rubbed on the penis when required, resulting in an erection in a few minutes, said de Lima.
The molecule triggers the release of nitric oxide, which is essential for an erection as it increases blood circulation and allows blood vessels to widen.
De Lima said the research could be especially useful in the fight against cancer, as men suffering prostate cancer often refuse a procedure to remove the prostate because it can damage nerves and lead to erectile dysfunction.
After the first phase of clinical trials was approved by Brazil's Anvisa regulatory agency, the medication has now moved into the second of three phases prior to being approved for sale.
De Lima said the discovery of a potential erectile dysfunction treatment was a message "not to destroy animals, even poisonous ones, because there is a real library of molecules that are still unknown."
Ch.P.Lewis--AT